Mesko: The Future of Critical Care Plenary #CCC50 #PedsICU
Mesko: how compassionate care can be combined with technology of the future. #CCC50 #PedsICU
Mesko: plays with the "what if" question. Science fiction is the engine that allows him to interact with current technologies #CCC50 #PedsICU
Mesko: using hypothetical analogy of aliens arriving in present day, to how central americans experienced Cortez arrival. #CCC50
Mesko: using mixed reality to help understand anatomy, better than simple 3D representations in an anatomy atlas. #CCC50 #PedsICU
Mesko: using MR to help teach medical students empathy, so they can experience a simulation of what their patients experience. #CCC50 #PedsICU
Mesko: lots of barriers to innovation in healthcare, shortages of physicians, lack of trust, lack of money, and current gap in care. #CCC50 #PedsICU
Mesko: 30 years to adopt the stethoscope. Lots of resistance to change. #CCC50 #PedsICU
Mesko: we are afraid of the unknown. Despite computer beating chess grand master in the 90s people still play chess, and chess play has gotten better. AI can be additive. Cultural transformation is needed. #CCC50 #PedsICU
Mesko: Digital health is a cultural transformation #CCC50 #PedsICU Point of care is shifting towards patients.
Mesko: in Rwanda today they are using 3D printers, drones to deliver medications to rural area, and other 'digital health' because they embraced it early #CCC50 #PedsICU
Mesko: embrace patient design, bring patients to the table so their voices can be heard. Things like round tables so they can look at the same table. Blue line on the floor where the physician acted like a doc, outside, they acted like a partner. #CCC50 #PedsICU
Mesko: everyone needs a patient advisory board. Hospitals, health care companies, pharma etc. #CCC50 #PedsICU
Mesko: even biologicals could be 3D printed. But also imagine a 3D printer available to print out all tailored needs at the bedside. Including PPE, equipment etc #CCC50 #PedsICU
Mesko: new member of the team will be Artificial Intelligence. Can do simple tests much better. But medicine is not simple. So this complements. #CCC50 #PedsICU (I'm good at capturing flattering facial expressions)
Mesko: interface isn't changed between provider and patient, but we're surrounded by technologies that support not interfere. Getting away from the keyboard. #CCC50 #PedsICU
Mesko: he's been living as a patient of the future on several levels (also microbiome test) these are all possibilities now #CCC50 #PedsICU
Mesko: two new team members: patient and AI, while you're surrounded by technology. medicalfuturist.com #CCC50 #PedsICU

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Ken Tegtmeyer, MD, FCCM, FAAP 🇺🇸

Ken Tegtmeyer, MD, FCCM, FAAP 🇺🇸 Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @pccm_doc

2 Feb
Sevransky: rationale for Vitamin C in sepsis and shock #CCC50 #PedsICU ImageImageImage
Sevransky: CITRIS-ALI #CCC50 #PedsICU 167 patients with Sepsis AND ARDS for < 24 hours. Image
Sevransky: it did raise Vitamin C levels but didn't modify SOFA or other scores. But interventional group had a lower mortality (not a primary outcome measure of the study though, one of 46 secondary measures) #CCC50 #PedsICU Billiard analogy of calling your shot - ImageImage
Read 12 tweets
2 Feb
Next up Joel Feih, PharmD from Froedtert Hospital at MCW in Milwaukee on B12 and Methylene Blue in refractory vasodilatory shock #CCC50 #PedsICU Image
Feih: Methylene Blue #CCC50 #PedsICU Image
Feih: Methylene Blue has been studied for prophylaxis in high risk vasoplegic syndrome following CPB #CCC50 #PedsICU ImageImage
Read 11 tweets
2 Feb
@KhannaAshishCCM reviewing stuff that I knew once upon a time... #CCC50 #PedsICU RAAS ImageImage
Khanna: Is renin the new lactate? #CCC50 #PedsICU ImageImageImage
Khana: case report of high renin vasodilatory shock in a COVID patient on VV ECMO aaa #CCC50 Image
Read 5 tweets
2 Feb
Douglas White (UPMC): ICU triaging both on saving most lives and those with longest life expectancy, even based on SOFA scores invariably will bias against patients of color, or lower SES #CCC50 #PedsICU Image
White: 4 strategies for ICU triage that promote equity ImageImage
White: Arizona as an example, some hospitals were overburdened, others had empty beds. Arizona surgeline addressed this to coordinate and facilitate transfer 5000 patient transfer so they didn't need to triage. #CCC50 #PedsICU Image
Read 10 tweets
2 Feb
Katri Typpo presenting the basic science arm of the Peds Year in Review (it's not all SARS-CoV2) #CCC50 #PedsICU
Typpo: looking at mechanism of Cytokine Release Syndrome in CAR-T therapy #CCC50 #PedsICU by Liu at al Blocking GSDME may prevent CRS Image
Typpo: an animal model of Inhaled Vitame E Acetate and EVALI-like Lung injury #CCC50 #PedsICU ImageImage
Read 8 tweets
2 Feb
Bembea presenting clinical arm of Year in Review, MIS-C, ARDS, here the PARDIE study #CCC50 #PedsICU Image
Bembea: PARK-PICU study looking at physical rehab point prevalence in the US from @SapnaKmd et al #CCC50 #PedsICU Image
Bembea: Canadian and European versions of PARK-PICU showed some similarities but some noticiable differences #CCC50 #PedsICU Image
Read 8 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!